Physician profile
Timothy P Pendleton
NPI 1801862693
$851.57
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $75.32 · 2021: $36.83 · 2022: $250 · 2023: $175 · 2024: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $205.53 | 2019-2024 | Trelegy Ellipta, Nucala |
| Janssen Pharmaceuticals, INC | $175.67 | 2019-2022 | |
| Grifols USA, LLC | $95.33 | 2019-2024 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $85.06 | 2022-2024 | Dupixent |
| Inspire Medical Systems, INC. | $80.45 | 2023-2024 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.29 | 2022-2024 | Lifevest |
| Baxter Healthcare | $40.88 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Pharmaceuticals Lp | $30.16 | 2022 | |
| Merck Sharp & Dohme LLC | $22.45 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.20 | 2019 | |
| Boston Scientific Corporation | $14.56 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $13.96 | 2023 | Caldolor |
| Philips North America LLC | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Pendleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.